{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:26:25Z","timestamp":1794979585041,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous studies have reported that inflammatory responses can promote the onset of cardiovascular diseases; however, its association with cardiac conduction disorders remains unclear. The present community-based cohort study aimed to elucidate the effects of inflammatory responses on the risk of developing cardiac conduction disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>After the exclusion of participants failing to meet the inclusion criteria, 86,234 eligible participants (mean age: 50.57\u2009\u00b1\u200911.88\u00a0years) were included. The participants were divided into high-sensitivity C-reactive protein (hsCRP) \u2009\u2264 \u20093\u00a0mg\/L, and hsCRP\u2009&gt;\u20093\u00a0mg\/L groups based on hsCRP values. Multivariate Cox proportional hazard model was used to analyze the relationship between inflammatory responses and various cardiac conduction disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After adjusting for confounding factors, we observed that compared with the hsCRP\u2009\u2264\u20093\u00a0mg\/L group, the hsCRP\u2009&gt;\u20093\u00a0mg\/L group exhibited increased risks of atrioventricular block (hazard ratio [HR]:1.64, 95%confidence interval [CI] 1.44\u20131.87) and left (HR:1.25, 95% CI 1.07\u20131.45) and right bundle branch block (HR:1.31, 95% CI 1.17\u20131.47). Moreover, the risk of various cardiac conduction disorders increased for every 1 standard deviation increase in log (hsCRP). The restricted cubic spline function confirmed a linear relationship between log (hsCRP) and the risk of developing cardiac conduction disorders (All nonlinearity <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>High hsCRP levels are an independent risk factor for cardiac conduction disorders, and hsCRP levels are dose-dependently associated with the risk of conduction disorders. Our study results may provide new strategies for preventing cardiac conduction disorders.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-01987-1","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T19:02:23Z","timestamp":1696100543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Elevated high-sensitivity C-reactive protein levels increase the risk of new-onset cardiac conduction disorders"],"prefix":"10.1186","volume":"22","author":[{"given":"Lili","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meimei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congliang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,30]]},"reference":[{"key":"1987_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/eurheartj\/eht176","volume":"35","author":"AL Aro","year":"2014","unstructured":"Aro AL, Anttonen O, Kerola T, Junttila MJ, Tikkanen JT, Rissanen HA, et al. Prognostic significance of prolonged PR interval in the general population. Eur Heart J. 2014;35:123\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/eht176.","journal-title":"Eur Heart J"},{"key":"1987_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.rec.2016.11.039","volume":"70","author":"GP Awamleh","year":"2017","unstructured":"Awamleh GP, Alonso JJ, Graupner AC, Jim\u00e9nez HR, Curcio RA, Talavera CP, et al. Investigators of the OFRECE Study Prevalence of electrocardiographic patterns associated with sudden cardiac death in the Spanish population aged 40 years or older: results of the OFRECE study. Rev Esp Cardiol. 2017;70:801\u20137. https:\/\/doi.org\/10.1016\/j.rec.2016.11.039.","journal-title":"Rev Esp Cardiol"},{"key":"1987_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.33963\/KP.14911","volume":"77","author":"A Piwo\u0144ska","year":"2019","unstructured":"Piwo\u0144ska A, Piwo\u0144ski J, Szcze\u015bniewska D, Drygas W. Population prevalence of electrocardiographic abnormalities: results of the Polish WAW-KARD study. Kardiol Pol. 2019;77:859\u201367. https:\/\/doi.org\/10.33963\/KP.14911.","journal-title":"Kardiol Pol"},{"key":"1987_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12872-021-02105-3","volume":"21","author":"RQ Shan","year":"2021","unstructured":"Shan RQ, Ning Y, Ma Y, Liu SL, Wu J, Fan XH, et al. Prevalence and risk factors of atrioventricular block among 15 million Chinese health examination participants in 2018: a nation-wide cross-sectional study. BMC Cardiovasc Disord. 2021;21:289. https:\/\/doi.org\/10.1186\/s12872-021-02105-3.","journal-title":"BMC Cardiovasc Disord"},{"key":"1987_CR5","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1001\/jama.2009.888","volume":"301","author":"S Cheng","year":"2009","unstructured":"Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA. 2009;301:2571\u20137. https:\/\/doi.org\/10.1001\/jama.2009.888.","journal-title":"JAMA"},{"key":"1987_CR6","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1001\/jama.2013.2729","volume":"309","author":"MC Mandyam","year":"2013","unstructured":"Mandyam MC, Soliman EZ, Heckbert SR, Vittinghoff E, Marcus GM. Long-term outcomes of left anterior fascicular block in the absence of overt cardiovascular disease. JAMA. 2013;309:1587\u20138. https:\/\/doi.org\/10.1001\/jama.2013.2729.","journal-title":"JAMA"},{"key":"1987_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/eurheartj\/ehac799","volume":"44","author":"EK Frimodt-M\u00f8ller","year":"2023","unstructured":"Frimodt-M\u00f8ller EK, Soliman EZ, Kizer JR, Vittinghoff E, Psaty BM, Biering-S\u00f8rensen T, et al. Lifestyle habits associated with cardiac conduction disease. Eur Heart J. 2023;44:1058\u201366. https:\/\/doi.org\/10.1093\/eurheartj\/ehac799.","journal-title":"Eur Heart J"},{"key":"1987_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/eurheartj\/ehac662","volume":"44","author":"H Saranda","year":"2023","unstructured":"Saranda H, Andrim H, Morten M, Ulrik PB, Berit TP, Tommi BL, et al. Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry. Eur Heart J. 2023;44:752\u201361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac662.","journal-title":"Eur Heart J"},{"key":"1987_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/eurheartj\/ehs291","volume":"34","author":"BE Bussink","year":"2013","unstructured":"Bussink BE, Holst AG, Jespersen L, Deckers JW, Jensen GB, Prescott E. Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen city heart study. Eur Heart J. 2013;34:138\u201346. https:\/\/doi.org\/10.1093\/eurheartj\/ehs291.","journal-title":"Eur Heart J"},{"key":"1987_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.7326\/0003-4819-90-3-303","volume":"90","author":"JF Schneider","year":"1979","unstructured":"Schneider JF, Thomas HE, Kreger BE, McNamara PM, Kannel WB. Newly acquired left bundle-branch block: the Framingham study. Ann Intern Med. 1979;90:303\u201310. https:\/\/doi.org\/10.7326\/0003-4819-90-3-303.","journal-title":"Ann Intern Med"},{"key":"1987_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3904\/kjim.2004.19.3.171","volume":"19","author":"JH Jeong","year":"2004","unstructured":"Jeong JH, Kim JH, Park YH, Han DC, Hwang KW, Lee DW, et al. Incidence of and risk factors for bundle branch block in adults older than 40 years. Korean J Intern Med. 2004;19:171\u20138. https:\/\/doi.org\/10.3904\/kjim.2004.19.3.171.","journal-title":"Korean J Intern Med"},{"key":"1987_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199\u2013210. https:\/\/doi.org\/10.1002\/path.2277.","journal-title":"J Pathol"},{"key":"1987_CR13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/cphy.c160046","volume":"7","author":"MN Nguyen","year":"2017","unstructured":"Nguyen MN, Kiriazis H, Gao XM, Du XJ. Cardiac Fibrosis and Arrhythmogenesis. Compr Physiol. 2017;7:1009\u201349. https:\/\/doi.org\/10.1002\/cphy.c160046.","journal-title":"Compr Physiol"},{"key":"1987_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1152\/physrev.00025.2003","volume":"84","author":"AG Kleber","year":"2004","unstructured":"Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagationand associated arrhythmias. Physiol Rev. 2004;84:431\u201388. https:\/\/doi.org\/10.1152\/physrev.00025.2003.","journal-title":"Physiol Rev"},{"key":"1987_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5935\/abc.20160005","volume":"106","author":"PS Azevedo","year":"2016","unstructured":"Azevedo PS, Polegato BF, Minicucci MF, Paiva SA, Zornoff LA. Car-diac remodeling: Concepts, clinical impact, pathophysiological mech-anisms and pharmacologic treatment. Arq Bras Cardiol. 2016;106:62\u20139. https:\/\/doi.org\/10.5935\/abc.20160005.","journal-title":"Arq Bras Cardiol"},{"key":"1987_CR16","doi-asserted-by":"publisher","first-page":"027247","DOI":"10.1161\/JAHA.122.027247","volume":"12","author":"EK Frimodt-M\u00f8ller","year":"2023","unstructured":"Frimodt-M\u00f8ller EK, Gottdiener JS, Soliman EZ, Kizer JR, Vittinghoff E, Psaty BM, et al. Inflammation and incident conduction disease. J Am Heart Assoc. 2023;12:027247. https:\/\/doi.org\/10.1161\/JAHA.122.027247.","journal-title":"J Am Heart Assoc"},{"key":"1987_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1161\/CIRCOUTCOMES.111.963694","volume":"5","author":"SL Wu","year":"2012","unstructured":"Wu SL, Huang ZR, Yang XC, Zhou Y, Wang AX, Chen L, et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes. 2012;5:487\u201393. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.111.963694.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1987_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1114248.","journal-title":"N Engl J Med"},{"key":"1987_CR19","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1097\/HJH.0000000000002453","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334\u201357. https:\/\/doi.org\/10.1097\/HJH.0000000000002453.","journal-title":"Hypertension"},{"key":"1987_CR20","doi-asserted-by":"publisher","first-page":"e3158","DOI":"10.1002\/dmrr.3158","volume":"35","author":"W Jia","year":"2019","unstructured":"Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35:e3158. https:\/\/doi.org\/10.1002\/dmrr.3158.","journal-title":"Diabetes Metab Res Rev"},{"key":"1987_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.cir.0000052939.59093.45","volume":"107","author":"AP Thomas","year":"2003","unstructured":"Thomas AP, George AM, Alexander RW, Anderson JL, Richard OC 3rd, Michael CQ, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the american heart association. Circulation. 2003;107:499\u2013511. https:\/\/doi.org\/10.1161\/01.cir.0000052939.59093.45.","journal-title":"Circulation"},{"key":"1987_CR22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"AE Epstein","year":"2008","unstructured":"Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the american college of cardiology\/american heart association task force on practice guidelines developed in collaboration with the american association for thoracic surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1\u201362. https:\/\/doi.org\/10.1016\/j.jacc.2008.02.032.","journal-title":"J Am Coll Cardiol"},{"key":"1987_CR23","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/j.jacc.2008.12.013","volume":"119","author":"B Surawicz","year":"2009","unstructured":"Surawicz B, Childers R, Deal BJ, Gettes LS, Bailey JJ, Gorgels A, et al. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation. 2009;119:e235\u201340. https:\/\/doi.org\/10.1016\/j.jacc.2008.12.013.","journal-title":"Circulation"},{"key":"1987_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-84882-778-3","volume-title":"The Minnesota code manual of electrocardio-graphic findings: standards and procedures for ECG measurement in epidemiologic and clinical trials","author":"RJ Prineas","year":"2010","unstructured":"Prineas RJ, Crow RS, Zhang ZM. The Minnesota code manual of electrocardio-graphic findings: standards and procedures for ECG measurement in epidemiologic and clinical trials. 2nd ed. London: Springer-Verlag; 2010.","edition":"2"},{"key":"1987_CR25","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","volume":"108","author":"RJ Aviles","year":"2003","unstructured":"Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006\u201310. https:\/\/doi.org\/10.1161\/01.CIR.0000103131.70301.4F.","journal-title":"Circulation"},{"key":"1987_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jacc.2010.02.066","volume":"56","author":"SC Marott","year":"2010","unstructured":"Marott SC, Nordestgaard BG, Zacho J, Friberg J, Jensen GB, Tybjaerg-Hansen A, et al. Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population. J Am Coll Cardiol. 2010;56:789\u201395. https:\/\/doi.org\/10.1016\/j.jacc.2010.02.066.","journal-title":"J Am Coll Cardiol"},{"key":"1987_CR27","doi-asserted-by":"publisher","first-page":"005610","DOI":"10.1161\/JAHA.117.005610","volume":"6","author":"A Wang","year":"2017","unstructured":"Wang A, Liu J, Li C, Gao J, Li X, Chen S, et al. Cumulative exposure to high-sensitivity c-reactive protein predicts the risk of cardiovascular disease. J Am Heart Assoc. 2017;6:005610. https:\/\/doi.org\/10.1161\/JAHA.117.005610.","journal-title":"J Am Heart Assoc"},{"key":"1987_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.118.034032","volume":"138","author":"EA Bohula","year":"2018","unstructured":"Bohula EA, Giugliano RP, Leiter LA, Verma S, Park JG, Sever PS, et al. Inflammatory and cholesterol risk in the FOURIER Trial. Circulation. 2018;138:131\u201340. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034032.","journal-title":"Circulation"},{"key":"1987_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12916-023-02770-5","volume":"21","author":"XR Yang","year":"2023","unstructured":"Yang XR, Zhao SH, Wang SH, Cao XL, Xu Y, Yan MC, et al. Systemic inflammation indicators and risk of incident arrhythmias in 478,524 individuals: evidence from the UK Biobank cohort. BMC Med. 2023;21:76. https:\/\/doi.org\/10.1186\/s12916-023-02770-5.","journal-title":"BMC Med"},{"key":"1987_CR30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41371-021-00546-z","volume":"35","author":"X Yang","year":"2021","unstructured":"Yang X, Zhang D, Zhao Y, Liu D, Li Q, Guo C, et al. Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies. J Hum Hypertens. 2021;35:1149\u201358. https:\/\/doi.org\/10.1038\/s41371-021-00546-z.","journal-title":"J Hum Hypertens"},{"key":"1987_CR31","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.jacc.2004.12.077","volume":"45","author":"C Kasapis","year":"2005","unstructured":"Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol. 2005;45:1563\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2004.12.077.","journal-title":"J Am Coll Cardiol"},{"key":"1987_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ypmed.2015.08.014","volume":"81","author":"PD Loprinzi","year":"2015","unstructured":"Loprinzi PD. Dose\u2013response association of moderate-to-vigorous physical activity with cardiovascular biomarkers and all-cause mortality: considerations by individual sports, exercise and recreational physical activities. Prev Med. 2015;81:73\u20137. https:\/\/doi.org\/10.1016\/j.ypmed.2015.08.014.","journal-title":"Prev Med"},{"key":"1987_CR33","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/eurheartj\/14.12.1590","volume":"14","author":"IS Thrainsdottir","year":"1993","unstructured":"Thrainsdottir IS, Hardarson T, Thorgeirsson G, Sigvaldason H, Sigfusson N. The epidemiology of right bundle branch block and its association with cardiovascular morbidity\u2013the Reykjavik Study. Eur Heart J. 1993;14:1590\u20136. https:\/\/doi.org\/10.1093\/eurheartj\/14.12.1590.","journal-title":"Eur Heart J"},{"key":"1987_CR34","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1515\/CCLM.2009.196","volume":"47","author":"YJ Lee","year":"2009","unstructured":"Lee YJ, Lee JH, Shin YH, Kim JK, Lee HR, Lee DC. Gender difference and determinants of C-reactive protein level in Korean adults. Clin Chem Lab Med. 2009;47:863\u20139. https:\/\/doi.org\/10.1515\/CCLM.2009.196.","journal-title":"Clin Chem Lab Med"},{"key":"1987_CR35","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/aje\/153.12.1183","volume":"153","author":"S Yamada","year":"2001","unstructured":"Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population\u202f: Jichi Medical School Cohort Study. Am J Epidemiol. 2001;153:1183\u201390. https:\/\/doi.org\/10.1093\/aje\/153.12.1183.","journal-title":"Am J Epidemiol"},{"key":"1987_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0021-9150(02)00380-5","volume":"167","author":"M Saito","year":"2003","unstructured":"Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis. 2003;167:73\u20139. https:\/\/doi.org\/10.1016\/s0021-9150(02)00380-5.","journal-title":"Atherosclerosis"},{"key":"1987_CR37","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/ijerph13090872","volume":"13","author":"Z Wang","year":"2016","unstructured":"Wang Z, Wang X, Chen Z, Zhang L, Zhu M. Distribution of High-Sensitivity C-Reactive Protein and Its relationship with other cardiovascular risk factors in the middle-aged chinese population. Int J Environ Res Public Health. 2016;13:872. https:\/\/doi.org\/10.3390\/ijerph13090872.","journal-title":"Int J Environ Res Public Health"},{"key":"1987_CR38","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s00125-020-05252-y","volume":"63","author":"MK Sung","year":"2020","unstructured":"Sung MK, Gyeongsil L, Seulggie C, Kyuwoong K, Su-Min J, Joung SS, et al. Association of early-onset diabetes, prediabetes and early glycaemic recovery with the risk of all-cause and cardiovascular mortality. Diabetologia. 2020;63:2305\u201314. https:\/\/doi.org\/10.1007\/s00125-020-05252-y.","journal-title":"Diabetologia"},{"key":"1987_CR39","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.jacc.2020.04.038","volume":"75","author":"C Wang","year":"2020","unstructured":"Wang C, Yuan Y, Zheng M, Pan A, Wang M, Zhao M, et al. Association of age of onset of hypertension with cardiovascular diseases and mortality. J Am Coll Cardiol. 2020;75:2921\u201330. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.038.","journal-title":"J Am Coll Cardiol"},{"key":"1987_CR40","doi-asserted-by":"publisher","unstructured":"Sun WP, Wu YQ, Gao MY, Tian Y, Qi P, Shen YJ, et al. C-reactive protein promotes inflammation through TLR4\/NF-\u03baB\/TGF-\u03b2 pathway in HL-1 cells. Biosci Rep 2019; 39: BSR20190888. https:\/\/doi.org\/10.1042\/BSR20190888","DOI":"10.1042\/BSR20190888"},{"key":"1987_CR41","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3892\/etm.2021.10247","volume":"22","author":"Y Xie","year":"2021","unstructured":"Xie Y, Li Q, Zhang HF, Huang TC, Yang Y, Lin YQ, et al. Effect of C reactive protein on the sodium-calcium exchanger 1 in cardiomyocytes. Exp Ther Med. 2021;22:815. https:\/\/doi.org\/10.3892\/etm.2021.10247.","journal-title":"Exp Ther Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01987-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01987-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01987-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T15:17:00Z","timestamp":1700320620000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01987-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1987"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01987-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,30]]},"assertion":[{"value":"1 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Kailuan General Hospital. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}